In Quest of Tablet Apps for Elders With Alzheimer's Disease

Tak, Sunghee H.

doi:10.1097/cin.0000000000000718

Cited by 4 publications

(4 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Concerning patients with dementia, Tak et al. ( 20 ) conducted a review of 83 applications used to improve symptoms and the quality of life for these patients. These applications aim not only to enhance cognitive abilities but also to address psychiatric symptoms such as apathy, irritability, agitation, social isolation, or sleep disturbances.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Musicotherapy mobile applications: what level of evidence and potential role in psychiatric care? A systematic review

Leschallier De Lisle,

Oudin,

Bourla

et al. 2024

Front. Psychiatry

View full text Add to dashboard Cite

ContextIn our times of smartphone ubiquity, mobile applications are an inescapable daily life tool, including in health care. Music therapy has already proven its worth, notably in mental health. Hence, we were interested in the mobile app format for this type of therapy, its level of evidence, how to use it in daily psychiatric care and the leads for future research and innovation.MethodThis study carries out a systematic review of scientific literature of this topic on two search engines, PubMed and PubPsych, using these key-words: [(web-application) OR (web-app) OR (smartphone) OR (apps) OR (app)) AND ((music) OR (music therapy) OR (melody)].OutcomeOut of a total of 282 studies found by keyword, 31 are included in this review. Several outcomes emerge. These studies relate to existing applications like Music Care, Calm or Unwind, on application prototypes or a potential use of music streaming applications on health care. They involve many different populations and clinical situations, including in hospital environments, for patients with chronic illnesses, different age ranges or for the general population. These musical interventions show a significant effect mainly for anxious symptoms, but also for depression, sleep disorders, pain and other psychiatric or psycho-somatic syndromes. These applications have no significant adverse effects.ConclusionThis review shows that music therapy apps have several potentials for improving mental health care. It could assist psychiatric usual care and could potentially lower medication intake. Nevertheless, the studies on the topic are limited and recent but they open prospects for future research.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Many studies also cite economic advantages. Mobile applications, without replacing the role and contribution of a human therapist, offer a cost-effective and accessible alternative for a broad range of individuals, especially for disadvantaged populations ( 6 , 20 , 30 , 43 ).…”

Section: Discussionmentioning

confidence: 99%

Musicotherapy mobile applications: what level of evidence and potential role in psychiatric care? A systematic review

Leschallier De Lisle,

Oudin,

Bourla

et al. 2024

Front. Psychiatry

View full text Add to dashboard Cite

show abstract

“…The WhatMatters app provides personalized support for dementia patients through caregivers [41]. Recommended mobile apps for people with AD and dementia were reviewed elsewhere [42][43][44].…”

Section: Alzheimer's Disease and Dementiamentioning

confidence: 99%

Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases

Biskupiak,

Ha,

Rohaj

et al. 2024

JCM

View full text Add to dashboard Cite

Limitations of pharmaceutical drugs and biologics for chronic diseases (e.g., medication non-adherence, adverse effects, toxicity, or inadequate efficacy) can be mitigated by mobile medical apps, known as digital therapeutics (DTx). Authorization of adjunct DTx by the US Food and Drug Administration and draft guidelines on “prescription drug use-related software” illustrate opportunities to create drug + digital combination therapies, ultimately leading towards drug–device combination products (DTx has a status of medical devices). Digital interventions (mobile, web-based, virtual reality, and video game applications) demonstrate clinically meaningful benefits for people living with Alzheimer’s disease, dementia, rheumatoid arthritis, cancer, chronic pain, epilepsy, depression, and anxiety. In the respective animal disease models, preclinical studies on environmental enrichment and other non-pharmacological modalities (physical activity, social interactions, learning, and music) as surrogates for DTx “active ingredients” also show improved outcomes. In this narrative review, we discuss how drug + digital combination therapies can impact translational research, drug discovery and development, generic drug repurposing, and gene therapies. Market-driven incentives to create drug–device combination products are illustrated by Humira® (adalimumab) facing a “patent-cliff” competition with cheaper and more effective biosimilars seamlessly integrated with DTx. In conclusion, pharma and biotech companies, patients, and healthcare professionals will benefit from accelerating integration of digital interventions with pharmacotherapies.

show abstract

“…Increasing applications have been developed to relieve caregivers’ burden. Six studies have evaluated the content and quality of applications for caregivers [ 27 , 28 , 29 , 30 , 31 , 32 ]. However, the difference between English-language and Chinese-language apps remains unclear.…”

Section: Introductionmentioning

confidence: 99%

A Survey of Mobile Apps for the Care Management of Patients with Dementia

Kuo

Chang

2022

Healthcare

View full text Add to dashboard Cite

Objective: Dementia is a progressive neurocognitive disorder that currently affects approximately 50 million people globally and causes a heavy burden for their families and societies. This study analyzed mobile apps for dementia care in different languages and during the COVID-19 pandemic. Methods: We searched PubMed, Cochrane Collaboration Central Register of Con-trolled Clinical Trials, Cochrane Systematic Reviews, Google Play Store, Apple App Store, and Huawei App Store for mobile applications for dementia care. The Mobile Application Rating Scale (MARS) was used to assess the quality of applications. Results: We included 99 apps for dementia care. No significant difference in MARS scores was noted between the two language apps (Overall MARS: English: 3.576 ± 0.580, Chinese: 3.569 ± 0.746, p = 0.962). In the subscale analysis, English apps had higher scores of perceived impact than Chinese apps but these were not significant (2.654 ± 1.372 vs. 2.000 ± 1.057, p = 0.061). (2) Applications during the COVID-19 pandemic had higher MARS scores than those before the COVID-19 pandemic but these were not significant (during the COVID-19 pandemic: 3.722 ± 0.416; before: 3.699 ± 0.615, p = 0.299). In the sub-scale analysis, apps during the COVID-19 pandemic had higher scores of engagement than apps before the COVID-19 pandemic but these were not significant (3.117 ± 0.594 vs. 2.698 ± 0.716, p = 0.068). Conclusions: Our results revealed that there is a minor but nonsignificant difference between different languages and during the COVID-19 pandemic. Further cooperation among dementia professionals, technology experts, and caregivers is warranted to provide evidence-based and user-friendly information to meet the needs of users.

show abstract

In Quest of Tablet Apps for Elders With Alzheimer's Disease

Cited by 4 publications

References 40 publications

Musicotherapy mobile applications: what level of evidence and potential role in psychiatric care? A systematic review

Musicotherapy mobile applications: what level of evidence and potential role in psychiatric care? A systematic review

Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases

A Survey of Mobile Apps for the Care Management of Patients with Dementia

Contact Info

Product

Resources

About